|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1505 - 0.1679|
|52 Week Range||0.0700 - 1.2400|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (the "Holders") of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures"). The Debt represents accrued interest on the ...
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.STENOCARE, located in Denmark, is a leading supplier of prescription-based medical cannabis products for patient treatment to help them improve ...
VANCOUVER, BC, Sept. 8, 2020 /CNW/ - Trading resumes in: Company: Emerald Health Therapeutics, Inc.